Gene · 6554
Papers3,134
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 3,134
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LINC01431 Promotes Histone H4R3 Methylation to Impede HBV Covalently Closed Circular DNA Transcription by Stabilizing PRMT1. | Adv Sci (Weinh) | 2022 | 35398991 | PubTator, text mining | PubMed |
| The relationship between NTCP gene varieties and the progress of liver disease after HBV infection: an updated systematic review and meta-analysis. | Am J Med Sci | 2022 | 35398032 | PubTator, text mining | PubMed |
| Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency-associated hypertransaminasemia. | Hepatology | 2022 | 35395098 | PubTator, text mining | PubMed |
| Regulation of Drug Transport Proteins-From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium. | Clin Pharmacol Ther | 2022 | 35390174 | PubTator, text mining | PubMed |
| Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients. | PLoS One | 2022 | 35390033 | PubTator, text mining | PubMed |
| Da-Chai-Hu-Tang Protects From Acute Intrahepatic Cholestasis by Inhibiting Hepatic Inflammation and Bile Accumulation via Activation of PPARα. | Front Pharmacol | 2022 | 35370715 | PubTator, text mining | PubMed |
| Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Disease. | Can J Gastroenterol Hepatol | 2022 | 35360442 | PubTator, text mining | PubMed |
| Replacement per- and polyfluoroalkyl substances (PFAS) are potent modulators of lipogenic and drug metabolizing gene expression signatures in primary human hepatocytes. | Toxicol Appl Pharmacol | 2022 | 35337807 | PubTator, text mining | PubMed |
| Special Issue: "Updates on HBV Infection". | Microorganisms | 2022 | 35336155 | PubTator, text mining | PubMed |
| The Association between ABCG2 421C>A (rs2231142) Polymorphism and Rosuvastatin Pharmacokinetics: A Systematic Review and Meta-Analysis | Pharmaceutics | 2022 | 35335877 | PubTator, text mining | PubMed |
| A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling. | Molecules | 2022 | 35335345 | PubTator, text mining | PubMed |
| Management of Delta Hepatitis 45 Years after the Discovery of HDV. | J Clin Med | 2022 | 35329913 | PubTator, text mining | PubMed |
| Structural Plasticity Is a Feature of Rheostat Positions in the Human Na+/Taurocholate Cotransporting Polypeptide (NTCP). | Int J Mol Sci | 2022 | 35328632 | PubTator, text mining | PubMed |
| Association Study of SLCO1B3 and ABCC3 Genetic Variants in Gallstone Disease. | Genes (Basel) | 2022 | 35328066 | PubTator, text mining | PubMed |
| Therapy of Chronic Viral Hepatitis: The Light at the End of the Tunnel? | Biomedicines | 2022 | 35327336 | PubTator, text mining | PubMed |
| The Role of Catecholamines in Pathophysiological Liver Processes. | Cells | 2022 | 35326472 | PubTator, text mining | PubMed |
| Viral hepatitis: Innovations and expectations. | World J Gastroenterol | 2022 | 35316960 | PubTator, text mining | PubMed |
| In vitro investigation of HBV clinical isolates from Chinese patients reveals that genotype C isolates possess higher infectivity than genotype B isolates. | Virol Sin | 2022 | 35314401 | PubTator, text mining | PubMed |
| The Detection and Verification of Two Heterogeneous Subgroups and a Risk Model Based on Ferroptosis-Related Genes in Hepatocellular Carcinoma. | J Oncol | 2022 | 35313563 | PubTator, text mining | PubMed |
| The kinesin KIF4 mediates HBV/HDV entry through the regulation of surface NTCP localization and can be targeted by RXR agonists in vitro. | PLoS Pathog | 2022 | 35312737 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6554/papers?page=44